SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes

Recent data have indicated the emerging role of glomerular autophagy in diabetic kidney disease. We aimed to assess the effect of the SGLT2 inhibitor empagliflozin, the DPP4 inhibitor linagliptin, and their combination, on glomerular autophagy in a model of type 2 diabetes. Eight-week-old male db/db...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Korbut, Anton I., Taskaeva, Iuliia S., Bgatova, Nataliya P., Muraleva, Natalia A., Orlov, Nikolai B., Dashkin, Maksim V., Khotskina, Anna S., Zavyalov, Evgenii L., Konenkov, Vladimir I., Klein, Thomas, Klimontov, Vadim V.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7215949/
https://ncbi.nlm.nih.gov/pubmed/32340263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21082987
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados